Michael Spohn

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Exome sequencing in 38 patients with intracranial aneurysms and subarachnoid hemorrhage.⚑
  2020 78/100 ⚑

1 assessed by us (1 reproduced) · 106 not yet assessed — every PubMed paper on record, linked below.

• Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models ↗

  2026
  not yet assessed
• Decompression of portal hypertension by transjugular intrahepatic portosystemic shunt reverses markers of gut barrier dysfunction and cirrhosis-associated immune dysfunction ↗

  Gut · 2026 · PMID 42532671
  not yet assessed
• Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models ↗

  Nature Genetics · 2025 · PMID 41381884
  not yet assessed
• Interferon Regulatory Factor 4 dose-dependently controls peripheral Treg cell differentiation and homeostasis by modulating chromatin accessibility in mice ↗

  Frontiers in Immunology · 2025 · PMID 40726986
  not yet assessed
• Genetic Risk Profiling Reveals Altered Glycosyltransferase Expression as a Predictor for Patient Outcome in Neuroblastoma ↗

  Journal of Clinical Medicine · 2025 · PMID 39860532
  not yet assessed
• A case report of a pediatric T-cell acute lymphoblastic leukemia with a subclonal <i>GCC2::PDGFRB</i> t(2;5) translocation – implementation for the selection of MRD-targets ↗

  Leukemia & lymphoma/Leukemia and lymphoma · 2025 · PMID 40108764
  not yet assessed
• Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  Cancer Immunology Research · 2025 · PMID 40168144
  not yet assessed
• WED-193 Resolution of portal hypertension by transjugular intrahepatic portosystemic shunt (TIPS) implantation reverses markers of gut-barrier dysfunction, systemic inflammation and anti-inflammatory monocyte alterations in patients with decompensated liver cirrhosis ↗

  Journal of Hepatology · 2025
  not yet assessed
• Glycosylation and Immune Evasion in Neuroblastoma ↗

  Klinische Pädiatrie · 2025
  not yet assessed
• Data from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S12 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S11 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S1 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S4 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S3 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S5 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S6 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S9 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Table S2 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Table S3 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Table S1 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S8 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S7 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S2 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Figure S10 from Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia ↗

  2025
  not yet assessed
• Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active proviruses ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025 · PMID 41040144
  not yet assessed
• Maternal <i>IGHG</i> locus duplications impair infants’ passive immunity ↗

  medRxiv · 2025
  not yet assessed
• Characterization of a PRKCE::ETV6 fusion as a potential oncogenic driver in T-cell acute lymphoblastic leukemia ↗

  Molecular and Cellular Pediatrics · 2025 · PMID 41123786
  not yet assessed
• Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells ↗

  Molecular Cancer · 2024 · PMID 38720314
  not yet assessed
• SMARCA4 Loss and Mutated β-Catenin Induce Proliferative Lesions in the Murine Embryonic Cerebellum ↗

  Journal of Neuroscience · 2024 · PMID 38383496
  not yet assessed
• CD301 and LSECtin glycan-binding receptors of innate immune cells serve as prognostic markers and potential predictors of immune response in breast cancer subtypes ↗

  Glycobiology · 2024 · PMID 38206856
  not yet assessed
• Expression of full-length FOXP3 exceeds other isoforms in thymus and stimulated CD4 + T cells ↗

  Journal of Clinical Immunology · 2024 · PMID 38676826
  not yet assessed
• IMMU-16. ANTI-VEGF TREATMENT EFFECT AGAINST GLIOMA IS IMMUNE DEPENDENT AND MEDIATED BY ENHANCED T CELL ACTIVITY ↗

  Neuro-Oncology · 2024
  not yet assessed
• Memory-like natural killer cell and CD19-antibody based immunotherapy in combination with tyrosine-kinase inhibition of Ph(-like) acute lymphoblastic leukemia ↗

  Research Square · 2024
  not yet assessed
• Adaptive NK cells in combination with tyrosine-kinase inhibition for the treatment of Ph- like ALL ↗

  Klinische Pädiatrie · 2024
  not yet assessed
• Transcriptomics-based characterization of the immuno-stromal microenvironment in pediatric low-grade glioma ↗

  OncoImmunology · 2024 · PMID 39135890
  not yet assessed
• Vertical transfer of maternal pathogen-specific antibodies in successive pregnancies and infection risk in infancy ↗

  Ultraschall in der Medizin - European Journal of Ultrasound · 2024
  not yet assessed
• P12.01.B ANTI-VEGF TREATMENT EFFECT AGAINST GLIOMA IS IMMUNE DEPENDENT AND MEDIATED BY ENHANCED T CELL ACTIVITY ↗

  Neuro-Oncology · 2024
  not yet assessed
• Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors ↗

  Circulation · 2023 · PMID 36802876
  not yet assessed
• Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures ↗

  Nature Communications · 2023 · PMID 38001143
  not yet assessed
• IRF4 is required for migration of CD4+ T cells to the intestine but not for Th2 and Th17 cell maintenance ↗

  Frontiers in Immunology · 2023 · PMID 37469513
  not yet assessed
• Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups ↗

  Neuro-Oncology · 2023 · PMID 36715306
  not yet assessed
• Short-term inulin supplementation comparably alters short-chain fatty acid (SCFA) production in healthy and chronic obstructive pulmonary disease (COPD) subjects ↗

  Clinical Nutrition ESPEN · 2023
  not yet assessed
• Supplementary Table 1 from An EGFR-Induced &lt;i&gt;Drosophila&lt;/i&gt; Lung Tumor Model Identifies Alternative Combination Treatments ↗

  2023
  not yet assessed
• Supplementary Table 3 from An EGFR-Induced &lt;i&gt;Drosophila&lt;/i&gt; Lung Tumor Model Identifies Alternative Combination Treatments ↗

  2023
  not yet assessed
• Supplementary Table 2 from An EGFR-Induced &lt;i&gt;Drosophila&lt;/i&gt; Lung Tumor Model Identifies Alternative Combination Treatments ↗

  2023
  not yet assessed
• Data from An EGFR-Induced &lt;i&gt;Drosophila&lt;/i&gt; Lung Tumor Model Identifies Alternative Combination Treatments ↗

  2023
  not yet assessed
• Supplementary Table 1 from An EGFR-Induced &lt;i&gt;Drosophila&lt;/i&gt; Lung Tumor Model Identifies Alternative Combination Treatments ↗

  2023
  not yet assessed
• Supplementary Table 2 from An EGFR-Induced &lt;i&gt;Drosophila&lt;/i&gt; Lung Tumor Model Identifies Alternative Combination Treatments ↗

  2023
  not yet assessed
• Supplementary Table 3 from An EGFR-Induced &lt;i&gt;Drosophila&lt;/i&gt; Lung Tumor Model Identifies Alternative Combination Treatments ↗

  2023
  not yet assessed
• Data from An EGFR-Induced &lt;i&gt;Drosophila&lt;/i&gt; Lung Tumor Model Identifies Alternative Combination Treatments ↗

  2023
  not yet assessed
• Vertical transfer of maternal pathogen-specific antibodies in successive pregnancies and infection risk in infancy ↗

  Journal of Reproductive Immunology · 2023
  not yet assessed
• 60P Adaptive NK cells as a therapeutic option for childhood leukaemia ↗

  Immuno-Oncology Technology · 2023
  not yet assessed
• Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine ↗

  Cell Reports Medicine · 2022 · PMID 35858586
  not yet assessed
• Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy ↗

  EMBO Molecular Medicine · 2022 · PMID 35938313
  not yet assessed
• Early-life exposure to tobacco smoke alters airway signaling pathways and later mortality in D. melanogaster ↗

  Environmental Pollution · 2022 · PMID 35780997
  not yet assessed
• Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies ↗

  Journal of Neuro-Oncology · 2022 · PMID 35190934
  not yet assessed
• Abstract 3374: Large-scale single-cell whole transcriptomic analyses reveal distinct malignant phenotypes of CTCs from NSCLC patients ↗

  Cancer Research · 2022
  not yet assessed
• PATH-04. Array-based global DNA Methylation profiling of mouse brain tumors allows comparison to human tumors ↗

  Neuro-Oncology · 2022
  not yet assessed
• ATRT-19. Functional genomics reveal distinct modulators of response to CDK4/6 inhibitors in ATRTs ↗

  Neuro-Oncology · 2022
  not yet assessed
• LGG-20. Defining subgroups in low grade gliomas by their immune and stromal microenvironment ↗

  Neuro-Oncology · 2022
  not yet assessed
• MEDB-41. Identifying a subgroup of patients with early childhood sonic hedgehog-activated medulloblastoma with unfavorable prognosis after treatment with radiation-sparing regimens including intraventricular methotrexate ↗

  Neuro-Oncology · 2022
  not yet assessed
• Infant immunity against viral infections is advanced by the placenta-dependent vertical transfer of maternal antibodies ↗

  Vaccine · 2021 · PMID 33431223
  not yet assessed
• Primary central nervous system sarcoma with <i>DICER1</i> mutation—treatment results of a novel molecular entity in pediatric Peruvian patients ↗

  Cancer · 2021 · PMID 34674226
  not yet assessed
• Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype ↗

  Acta Neuropathologica · 2021 · PMID 33844070
  not yet assessed
• Brahma-related gene 1 has time-specific roles during brain and eye development ↗

  Development · 2021 · PMID 34042968
  not yet assessed
• Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2 ↗

  Stem Cell Research · 2021 · PMID 34607262
  not yet assessed
• Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia ↗

  Blood Advances · 2021 · PMID 33646306
  not yet assessed
• Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group ↗

  Haematologica · 2021
  not yet assessed
• The Polycomb Protein Bmi1 is a Key Effector of the H3.3 K27m Oncohistone ↗

  SSRN Electronic Journal · 2021
  not yet assessed
• Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases ↗

  Acta Neuropathologica · 2020 · PMID 33331994
  not yet assessed
• Defining Culture Conditions for the Hidden Nitrite-Oxidizing Bacterium Nitrolancea ↗

  Frontiers in Microbiology · 2020 · PMID 32849321
  not yet assessed
• High-resolution analysis of Merkel Cell Polyomavirus in Merkel Cell Carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanisms ↗

  PLoS Pathogens · 2020 · PMID 32833988
  not yet assessed
• EBV renders B cells susceptible to HIV-1 in humanized mice ↗

  Life Science Alliance · 2020 · PMID 32576602
  not yet assessed
• Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas ↗

  Journal of Neuropathology & Experimental Neurology · 2020 · PMID 33270865
  not yet assessed
• Exome sequencing in 38 patients with intracranial aneurysms and subarachnoid hemorrhage⚑

  Journal of Neurology · 2020 · PMID 32367296
  78/100 ⚑
• Merkel Cell Polyomavirus DNA Replication Induces Senescence in Human Dermal Fibroblasts in a Kap1/Trim28-Dependent Manner ↗

  mBio · 2020 · PMID 32156811
  not yet assessed
• Case Report on: Very Early Afterdepolarizations in HiPSC-Cardiomyocytes—An Artifact by Big Conductance Calcium Activated Potassium Current (Ibk,Ca) ↗

  Cells · 2020 · PMID 31968557
  not yet assessed
• Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer ↗

  Clinical & Experimental Metastasis · 2020 · PMID 33099724
  not yet assessed
• Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model ↗

  Cancer Letters · 2020 · PMID 32112900
  not yet assessed
• Influence of anti-thymocyte globulin plasma levels on outcome parameters in stem cell transplanted children ↗

  International Immunopharmacology · 2020 · PMID 32197227
  not yet assessed
• Genomic and phylogenetic analysis of two guinea pig adenovirus strains recovered from archival lung tissue ↗

  Virus Research · 2020 · PMID 32311385
  not yet assessed
• High-resolution analysis of Merkel Cell Polyomavirus in Merkel Cell Carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanisms ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• MBCL-09. ISOLATED M1 METASTASES IN PEDIATRIC MEDULLOBLASTOMA: IS POSTOPERATIVE RADIOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY SUPERIOR TO POSTOPERATIVE SANDWICH-CHEMOTHERAPY AND RADIOTHERAPY? ↗

  Neuro-Oncology · 2020
  not yet assessed
• Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy ↗

  EMBO Molecular Medicine · 2019 · PMID 31680489
  not yet assessed
• Extremophilic nitrite-oxidizing <i>Chloroflexi</i> from Yellowstone hot springs ↗

  The ISME Journal · 2019 · PMID 31624340
  not yet assessed
• Molecular characterization of histopathological ependymoma variants ↗

  Acta Neuropathologica · 2019 · PMID 31679042
  not yet assessed
• TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma ↗

  Acta Neuropathologica · 2019 · PMID 30830316
  not yet assessed
• The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration ↗

  Acta Neuropathologica Communications · 2019 · PMID 31806049
  not yet assessed
• An EGFR-Induced <i>Drosophila</i> Lung Tumor Model Identifies Alternative Combination Treatments ↗

  Molecular Cancer Therapeutics · 2019 · PMID 31217165
  not yet assessed
• The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice ↗

  Scientific Reports · 2019 · PMID 30890743
  not yet assessed
• PATH-16. HISTOPATHOLOGICAL EPENDYMOMA VARIANTS ARE ASSOCIATED WITH DISTINCT CLINICAL PARAMETERS AND DNA METHYLATION PATTERNS ↗

  Neuro-Oncology · 2019
  not yet assessed
• Expression of a Structural Protein of the Mycovirus FgV-ch9 Negatively Affects the Transcript Level of a Novel Symptom Alleviation Factor and Causes Virus Infection-Like Symptoms in Fusarium graminearum ↗

  Journal of Virology · 2018 · PMID 29899100
  not yet assessed
• Identification of virus-encoded microRNAs in divergent Papillomaviruses ↗

  PLoS Pathogens · 2018 · PMID 30048533
  not yet assessed
• Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV ↗

  Vaccine · 2018 · PMID 30244872
  not yet assessed
• Interaction between the cellular E3 ubiquitin ligase SIAH-1 and the viral immediate-early protein ICP0 enables efficient replication of Herpes Simplex Virus type 2 in vivo ↗

  PLoS ONE · 2018 · PMID 30080903
  not yet assessed
• ATRT-21. COMPARATIVE INTEGRATIVE ANALYSIS OF PRIMARY AND RELAPSED ATYPICAL TERATOID/RHABDOID TUMORS (AT/RTs) ↗

  Neuro-Oncology · 2018
  not yet assessed
• Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs) ↗

  Klinische Pädiatrie · 2018
  not yet assessed
• Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression ↗

  Cell Host & Microbe · 2017 · PMID 28704654
  not yet assessed
• Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization ↗

  EBioMedicine · 2017 · PMID 28434944
  not yet assessed
• Spontaneous lung metastasis formation of human Merkel cell carcinoma cell lines transplanted into scid mice ↗

  International Journal of Cancer · 2017 · PMID 28380668
  not yet assessed
• Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems ↗

  PLoS ONE · 2016 · PMID 27341108
  not yet assessed
• Runx1 downregulates stem cell and megakaryocytic transcription programs that support niche interactions ↗

  Blood · 2016 · PMID 27076172
  not yet assessed
• Complete Genome Sequence of a Human Cytomegalovirus Strain AD169 Bacterial Artificial Chromosome Clone ↗

  Genome Announcements · 2016 · PMID 27034483
  not yet assessed
• O5 CRISPR/Cas9-derived activation systems as new tools for induction of latent human immunodeficiency virus (HIV) ↗

  Journal of Virus Eradication · 2016
  not yet assessed
• Evaluation of Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples ↗

  Journal of Clinical Microbiology · 2015 · PMID 25972420
  not yet assessed
• Essential control of early B-cell development by Mef2 transcription factors ↗

  Blood · 2015 · PMID 26660426
  not yet assessed